Technical Analysis for GUD - Knight Therapeutics Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.19% | |
| Narrow Range Bar | Range Contraction | 0.19% | |
| 180 Bearish Setup | Bearish Swing Setup | 1.36% | |
| Gapped Down | Weakness | 1.36% | |
| Oversold Stochastic | Weakness | 1.36% | |
| Oversold Stochastic | Weakness | -2.79% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.58% | |
| Calm After Storm | Range Contraction | 0.58% | |
| Oversold Stochastic | Weakness | 0.58% | |
| Lower Bollinger Band Walk | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 10 minutes ago |
| 10 DMA Support | 24 minutes ago |
| Possible NR7 | about 20 hours ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 3% | 2 days ago |
Get a Trading Assistant
- Earnings date: 2024-11-07
Knight Therapeutics Inc. Description
Knight Therapeutics Inc is a Canada-based pharmaceutical company. The Company is engaged in developing, acquiring, in-licensing, out-licensing, marketing and distributing pharmaceutical products, consumer health products and medical devices in Canada and select international markets. It finances other life sciences companies in Canada and internationally. Its prescription pharmaceuticals and medical devices in various stages of development include Impavido, AzaSite, ATryn, Photofrin, ILUVIEN, TULSA-PRO, PROBUPHINE, Advaxis Family of Products, Ember Family of Products, NeurAxon Family of Products, Antibe Family of Products, Blood Factor Products and VEWS Vascular Early Warning System. In addition, the Company also has a portfolio of branded consumer health products, including Neuragen, Flat Tummy Tea, FOCUSFactor, FLEXISEQ, SEQuaderma, HandMD, UrgentRx, Laboratoire Dr. Renaud, Premiology and Pro-Derm.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Marketing Pharma Pharmaceutical Labor Science Pharmaceuticals Life Sciences Pharmaceutical Products Pharmaceutical Industry Medical Devices Pharmaceutical Sciences Consumer Health Products Pharmaceutical Industry In China
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.23 |
| 52 Week Low | 5.07 |
| Average Volume | 86,762 |
| 200-Day Moving Average | 5.657 |
| 50-Day Moving Average | 5.686 |
| 20-Day Moving Average | 5.423 |
| 10-Day Moving Average | 5.198 |
| Average True Range | 0.146 |
| RSI (14) | 40.48 |
| ADX | 25.1 |
| +DI | 17.316 |
| -DI | 24.521 |
| Chandelier Exit (Long, 3 ATRs) | 5.382 |
| Chandelier Exit (Short, 3 ATRs) | 5.523 |
| Upper Bollinger Bands | 5.889 |
| Lower Bollinger Band | 4.956 |
| Percent B (%b) | 0.27 |
| BandWidth | 17.202 |
| MACD Line | -0.140 |
| MACD Signal Line | -0.127 |
| MACD Histogram | -0.0122 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.300 | ||||
| Resistance 3 (R3) | 5.290 | 5.250 | 5.285 | ||
| Resistance 2 (R2) | 5.250 | 5.227 | 5.255 | 5.280 | |
| Resistance 1 (R1) | 5.230 | 5.213 | 5.240 | 5.240 | 5.275 |
| Pivot Point | 5.190 | 5.190 | 5.195 | 5.195 | 5.190 |
| Support 1 (S1) | 5.170 | 5.167 | 5.180 | 5.180 | 5.145 |
| Support 2 (S2) | 5.130 | 5.153 | 5.135 | 5.140 | |
| Support 3 (S3) | 5.110 | 5.130 | 5.135 | ||
| Support 4 (S4) | 5.120 |
